-
07:27:23 PM
Sign in with email
Forgot your password?
Register with email
Account Verification

CANF Stock News

11/01/21 7:00 AM
AMEX : CANF
low float
Can-Fite’s Findings on Cannabis Compound’s Inhibition of Liver Cancer are Published in HEPATOLOGY and will be Presented at the AASLD’s The Liver Meeting® 2021 Conference
Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced the Company’ s CEO Dr. Pnina Fishman will deliver a poster presentation titled“ Growth Inhibition of Hepatocellular Carcinoma by CBD Rich T3/C15 Cannabis...
RHEA-AI
neutral
10/26/21 7:00 AM
AMEX : CANF
conferencesclinical triallow float
Can-Fite CEO to Present Namodenoson’s Clinical Trial Data as Expert Speaker at 5th Annual Antifibrotic Drug Development Summit
Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced the Company’ s CEO Dr. The 5th Annual Antifibrotic Drug Development Summit will be held on November 1– 3, 2021. Dr. Fishman will present on Wednesday, November 3 at...
RHEA-AI
neutral
10/05/21 7:00 AM
AMEX : CANF
conferenceslow float
Can-Fite to Present at H.C. Wainwright 5th Annual NASH Investor Conference on October 12, 2021
Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced the Company’ s CEO Dr. Wainwright 5 th Annual NASH Investor Conference at 9:30 am ET on Tuesday, October 12, 2021. NASH is a clear and urgent unmet medical need, as...
RHEA-AI
neutral
09/22/21 7:00 AM
AMEX : CANF
low float
Can-Fite CEO to Join Benzinga Medical Cannabis Panel and Deliver Company Presentation at Healthcare Small Cap Conference on September 29, 2021
Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced the Company’ s CEO Dr. Pnina Fishman will present at the Benzinga Healthcare Small Cap Conference on September 29, 2021 and will join a panel discussion regarding medical cannabis.
RHEA-AI
neutral